NASDAQ:MMSI • US5898891040
The current stock price of MMSI is 81.66 USD. In the past month the price increased by 1.63%. In the past year, price decreased by -24.49%.
ChartMill assigns a technical rating of 1 / 10 to MMSI. When comparing the yearly performance of all stocks, MMSI is a bad performer in the overall market: 80.47% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to MMSI. MMSI scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months MMSI reported a non-GAAP Earnings per Share(EPS) of 3.72. The EPS increased by 10.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.02% | ||
| ROA | 4.5% | ||
| ROE | 7.74% | ||
| Debt/Equity | 0.48 |
17 analysts have analysed MMSI and the average price target is 106.45 USD. This implies a price increase of 30.36% is expected in the next year compared to the current price of 81.66.
For the next year, analysts expect an EPS growth of 9.63% and a revenue growth 11.74% for MMSI
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.79 | 58.526B | ||
| COO | COOPER COS INC/THE | 18.19 | 16.264B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.67 | 13.401B | ||
| SOLV | SOLVENTUM CORP | 11.67 | 13.104B | ||
| LNTH | LANTHEUS HOLDINGS INC | 12.27 | 4.601B | ||
| ICUI | ICU MEDICAL INC | 17.67 | 3.578B | ||
| HAE | HAEMONETICS CORP/MASS | 10.52 | 2.684B | ||
| XRAY | DENTSPLY SIRONA INC | 8.32 | 2.584B | ||
| NEOG | NEOGEN CORP | 32.26 | 2.38B |
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 7,400 full-time employees. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. The company also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
MERIT MEDICAL SYSTEMS INC
1600 West Merit Park Way
South Jordan UTAH 84095 US
CEO: Fred P. Lampropoulos
Employees: 7400
Phone: 18012531600
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 7,400 full-time employees. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. The company also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
The current stock price of MMSI is 81.66 USD. The price increased by 3.55% in the last trading session.
MMSI does not pay a dividend.
MMSI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
MMSI stock is listed on the Nasdaq exchange.
MERIT MEDICAL SYSTEMS INC (MMSI) has a market capitalization of 4.84B USD. This makes MMSI a Mid Cap stock.
The outstanding short interest for MERIT MEDICAL SYSTEMS INC (MMSI) is 6.47% of its float.